[19:51] Dr
Management of obesity in Prader-Willi syndrome
Other working group members include: NGA Vice Chair Maryland Governor Wes Moore Colorado Governor Jared Polis Connecticut Governor Ned Lamont Indiana Governor Mike Braun Louisiana Governor Jeff Landry Massachusetts Governor Maura Healey North Dakota Governor Kelly Armstrong Rhode Island Governor Dan McKee Tennessee Governor Bill Lee Utah Governor Spencer Cox Wyoming Governor Mark Gordon NGA Details Ways Governors Can Improve Maternal Health Through the Rural Health Transformation Program NGA Details Ways Governors Can Improve Maternal Health Through the Rural Health Transformation Program All 50 States Submit Applications to Transform Rural Health In a new commentary, NGA and the Policy Center for Maternal Mental Health explore ways Governors can improve maternal mental health through the Rural Health Transformation Program (RHTP)
[5] [6] Once administered intramuscularly (usually into the deltoid or gluteal muscle), hydroxocobalamin is rapidly absorbed into the circulation
Per Humana's pharmacy policy (effective 1/20/2025), Medicare covers Zepbound for OSA if you meet ALL of these: (1) moderate-to-severe OSA (AHI 15), (2) BMI 27 or higher, (3) using it with lifestyle modifications, and (4) you do NOT have type 1 or type 2 diabetes
Tirzepatide may not fit research involving: Treatment-resistant, severe obesity (where maximum lipolysis is required) Models requiring increased energy expenditure Advanced non-alcoholic steatohepatitis (NASH) where liver fat oxidation is the primary target Retatrutide may not fit research involving: Subjects with a history of severe gastrointestinal sensitivity Models where extreme nausea or tachycardia (elevated heart rate) would confound the data Pure Type 2 Diabetes models (where Glucagon stimulation is counterproductive to glycemic control) Common Mistakes Mistake: Dosing Retatrutide at the same speed as Tirzepatide